1. shastaflower66
2. jimneal
1.jimneal 03/30/2018
Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress
2.shastaflower66 03/16/2018
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW